Abstract
People who pursue unproven therapies are often portrayed as ‘desperate’ individuals duped by medical racketeers peddling ‘false hope’. These patients, in contrast, present themselves as empowered citizens who have taken an informed decision to pursue an experimental therapy. This paper explores the latter perspective through the case of the so-called ‘liberation procedure’: a controversial endovascular intervention proposed as a treatment for Multiple Sclerosis (MS). Drawing on interviews with 48 people affected by MS, we analyse the decision-making processes and justifications thereof of those who had the procedure (n = 31). While the decision to have the intervention might not have been justified according to the standards of evidence-based medicine, it was nonetheless premised on a shared ‘experiential logic’ – conceptualised as a logic of embodied risk/hope – that extends beyond the specific condition and therapy in question. The paper explicates this logic, concentrating on patients’ negotiations of (a) risk and uncertainty; (b) expertise and evidence; and (c) hope and experiment. In particular, we foreground how, through a combination of therapeutic experimentation and experiential information sharing, patients turn their own bodies into (contested) sources of hope for themselves and others, which, in turn, shapes their embodied experiences of living with MS in the present.
Similar content being viewed by others
Notes
On the rise of medical travel (or ‘transnational healthcare’ as some, like Botterill et al (2013) and Bell et al (2015), prefer to call it) as well as the widespread attention, it has received from the media, academics, medical practitioners and policy-makers see Turner (2007), Murdoch and Scott (2010), Whittaker et al (2010).
Our use of ‘logic’ is not meant to imply that the patients’ decisions were ‘logical’ or ‘rational’ in the sense that we have judged them to be ‘justified’ or ‘sound’. Rather we use the terms to signify that the practices we analyse have an internal coherence, albeit one that differs from the dominant logics of biomedicine. There are a number of alternative social scientific terms and concepts that we could have drawn on here, such as discourse, mode of ordering, regime or style. Taking inspiration from Annemarie Mol’s use of the term (Mol, 2008, p. 8), we use logic to indicate that the practices we explore have an underlying, if contingent and fragile, rationality that holds them together, linking words, practices and materialities in particular situated ways. In addition, we chose to use logic over other possible alternatives because it chimes with how our interviewees described their decision-making practices and would be recognisable to them.
A number of private medical ‘tourist’ clinics in countries such as Poland, Bulgaria, India and Cost Rica offered the intervention. It was available privately in the US and UK (in some cases as part of research studies, although patients still had to pay). Initially, if the patient could find an interventional radiologist willing to perform the procedure it was available in Australia, but finding someone willing to do so was not easy. As the intervention gained increased media attention and become more controversial, many of the radiologists and clinics that offered it stopped doing so. Costs varied greatly depending on country, radiologist, number of angioplasties and/or stents and could be anywhere between $10,000 and $15,000 per procedure, excluding travel and accommodation.
Zamboni initially proposed the idea that vascular abnormalities might play a role in MS in 2006 (Zamboni, 2006). However, it was with the publication of the research studies in 2009 that his work started to receive widespread international attention from patient groups, the media and MS researchers.
At the time of writing, the most recent update on CCSVI-related research was a presentation given by Anthony Traboulsee (Associate Professor of Neurology at the University of British Columbia) at the Society for Interventional Radiology’s annual scientific meeting on the 8th of March 2017. Based on an unpublished double-blinded trial of 104 people with MS, the study found no association between venous angioplasty and improvement in MS symptoms 48 weeks post the intervention (Mulholland, 2017). Zamboni’s much awaited BRAVE DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosis) trial has yet to be completed (http://bravedreams.ccsvi-sm.org/). While support for the liberation procedure has dwindled, many people believe the intervention had a positive effect on their health and activists continue to support further research, for example, the CCSVI Alliance (http://ccsvi.org/), the Canadian Neurovascular Health Society (http://www.cnhs.ca/) and CCSVI Australia (http://ccsviaustralia.com.au/).
Natalizumab, a DMD for highly active MS.
An opioid believed to have a positive effect on the immune system.
The question of what medical specialism and expertise is best suited to researching and treating MS is a long-standing one and has been the cause of divisions in the field in the past. For more on the wider historical context of such debates, see Nicolson and McLaughlin (1988) and Nicolson and Lowis (2002).
We use ‘regime of truth’ here to indicate particular logics and associated forms of evidence, rather than the full Foucauldian sense of the term (Foucault, 1991).
Although MS is not strictly speaking a genetic disease, it has long been believed that there is a genetic component. For more on genetics in MS see Hoppenbrouwers and Hintzen (2011).
Titled “The Liberation Treatment: A whole new approach to MS”; this documentary was aired in November 2009 on CTV news’ current affairs programme W5 (http://www.ctvnews.ca/the-liberation-treatment-a-whole-new-approach-to-ms-1.456617).
Video available at: https://www.youtube.com/watch?v=pjOvd4PBnoo, accessed 12 November 2016.
References
Adams, V., Murphy, M. and Clarke, A.E. (2009) Anticipation: Technoscience, life, affect, temporality. Subjectivity 28: 246–265.
Adamson, C. (1997) Existential and clinical uncertainty in the medical encounter: An idiographic account of an illness trajectory defined by Inflammatory Bowel Disease and Avascular Necrosis. Sociology of Health and Illness 19(2): 133–159.
Baracchini, C., Valdueza, J.M., Del Sette, M., Baltgaile, G., Bartels, E., Bornstein, N.M. and Klingelhoefer, J. (2012) CCSVI and MS: A statement from the European Society of Neurosonology and Cerebral Hemodynamics. Journal of Neurology 259(12): 2585–2589.
BBC (2011) Concerns about controversial MS treatment. 7 March, http://www.bbc.co.uk/news/health-12637191, accessed 12 November 2016.
Bell, D., Holliday, R. Ormond, M. and Mainil, T. (2015) Transnational healthcare, cross-border perspectives. Social Science and Medicine 124: 284–289.
Berg, B.L. (2009) Qualitative Research Methods for the Social Sciences. 7th edition. Boston, MA: Pearson.
Berlant, L. (2011) Cruel Optimism. Durham, NC: Duke University Press Books.
Botterill, D., Pennings, G. and Mainil, T. (eds.) (2013) Medical Tourism and Transnational Health Care. Basingstoke: Palgrave Macmillan.
Bowling, A.C. (2011) Complementary and alternative medicine and multiple sclerosis. Neurologic Clinics 29(2): 465–480.
Callon, M. and Rabeharisoa, V. (2003) Research ‘in the wild’ and the shaping of new social identities. Technology in Society 25(2): 193–204.
Caron-Flinterman, J.F., Broerse, J.E.W. and Bunders, J.F.G. (2005) The experiential knowledge of patients: A new resource for biomedical research? Social Science and Medicine 60(11): 2575–2584.
Chafe, R., Born, K.B., Slutsky, A.S. and Laupacis, A. (2011) The rise of people power. Nature 472(7344): 410–411.
CIHR (2011) Systematic reviews of the evidence regarding chronic cerebral spinal venous insufficiency (CCSVI) and multiple sclerosis – Summary of second report for CIHR expert panel, November 21, http://www.cihr-irsc.gc.ca/e/44559.html?=undefined&wbdisable=false, accessed 12 November 2016.
Collins, H. and Evans, R. (2002) The third wave of science studies: Studies of expertise and experience. Social Studies of Science 32(2): 235–296.
Compston, A. and Coles, A. (2008) Multiple Sclerosis. Lancet 372(9648): 1502–1517.
Cooper, M. and Waldby, C. (2014) Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy. Durham, NC: Duke University Press.
Di Blasi, Z., Harkness, E., Ernst, E., Georgiou, A. and Kleijnen, J. (2001) Influence of context effects on health outcomes: A systematic review. Lancet 357(9258): 757–762.
Doepp, F., Paul, F., Valdueza, J.M., Schmierer, K. and Schreiber, S.J. (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Annals of Neurology 68(2): 173–183.
Epstein, S. (1995) The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Science, Technology and Human Values 20(4): 408–437.
Epstein, S. (1996) Impure Science: AIDS, Activism and the Politics of Knowledge. Berkeley: University of California Press.
Fayerman, P. (2013) The final curtain on CCSVI and liberation therapy for multiple sclerosis. Vancouver Sun (2013), 10 October, http://vancouversun.com/news/staff-blogs/the-final-curtain-on-ccsvi-and-liberation-therapy-for-multiple-sclerosis, accessed 12 November 2016.
FDA (2012) News alert: FDA issues alert on potential dangers of unproven treatment for multiple sclerosis, 10 May, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303538.htm, accessed 12 November 2016.
Foucault, M. (1991) Politics and the study of discourse. In G. Burchell et al. (eds.) The Foucault Effect: Studies in Governmentality. London: Harvester Wheat-sheaf, pp. 53–72.
Gafson, A.R. and Giovannoni, G. (2014) CCSVI: A call to clinicians and scientists to vocalise in an internet age. Multiple Sclerosis and Related Disorders 3(2): 143–146.
Grady, D. (2010) From MS patients, outcry for unproved treatment. New York Times, 28 June.
Hakim E.A., Bakheit A.M.O., Bryant T.N., Roberts M.W.H., McIntosh-Michaelis S.A., Spackman A.J., Martin J.P. and McLellan D.L. (2000) The social impact of multiple sclerosis: A study of 305 patients and their relatives. Disability and Rehabilitation 22(April): 288–293.
Hamilton, R.J. and Bowers, B.J. (2006) Internet recruitment and e-mail interviews in qualitative studies. Qualitative Health Research 16(6): 821–835.
Heaton, J. (2004) Reworking Qualitative Data. London: Sage.
Hoppenbrouwers, I.A. and Hintzen, R.Q. (2011) Genetics of multiple sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Molecular Basis of Multiple Sclerosis, 1812(2): 194–201.
Johnson, A.G (1994) Surgery as a Placebo. Lancet 344(8930): 1140–1142.
Kavanagh, A.M. and Broom, D. H. (1998) Embodied risk: My body, myself? Social Science and Medicine 46(3): 437–444.
Koschack, J., Weibezahl, L., Friede, T. Himmel, W., Makedonski, P. and Grabowski, J. (2015) Scientific versus experiential evidence: Discourse analysis of the chronic cerebrospinal venous insufficiency debate in a multiple sclerosis forum. Journal of Medical Internet Research 17(7): e159.
Laupacis, A. and Slutsky, A.S. (2010) Endovascular treatment for multiple sclerosis: The intersection of science, policy and the public. Open Medicine 4: e197–199.
Laupacis, A., Lillie, E., Dueck, A., Straus, S. Perrier, L., Burton, J.M., Aviv, R., Thorpe, K., Feasby, T. and Spears, J. (2011) Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: A meta-analysis. Canadian Medical Association Journal 183(16): E1203–E1212.
Lexell, E.M., Larsson Lund, M. and Iwarsson, S. (2009) Constantly changing lives: Experiences of people with multiple sclerosis. The American Journal of Occupational Therapy 63(6): 772–781.
Lupton, D. and Tulloch, J. (2002) ‘Risk is part of your life’: Risk epistemologies among a group of Australians. Sociology 36(2): 317–334.
Mattingly, C. (2010) The Paradox of Hope: Journeys Through a Clinical Borderland. Berkeley: University of California Press.
Mayer, C. A., Pfeilschifter, W. Lorenz, M.W., Nedelmann, M. Bechmann, I., Steinmetz, H. and Ziemann, U. (2011) The perfect crime? CCSVI not leaving a trace in MS. Journal of Neurology, Neurosurgery and Psychiatry 82(4): 436–440.
Mazanderani, F., O’Neill, B. and Powell, J. (2013) ‘People power’ or ‘pester power’? YouTube as a forum for the generation of evidence and patient advocacy. Patient Education and Counseling 93(3): 420–425.
McCoyd, J.L.M. and Schwaber Kerson, T. (2006) Conducting intensive interviews using email a Serendipitous comparative opportunity. Qualitative Social Work 5(3): 389–406.
Meakins, J.L. (2002) Innovation in surgery: The rules of evidence. The American Journal of Surgery 183(4): 399–405.
Miyazaki, H. (2006) The Method of Hope: Anthropology, Philosophy, and Fijian Knowledge. Stanford: Stanford University Press.
Mol, A. (2008) The Logic of Care: Health and the Problem of Patient Choice. Abingdon: Routledge.
Moreira, T. and Palladino, P. (2005) Between truth and hope: On Parkinson’s disease, neurotransplantation and the production of the ‘self’. History of the Human Sciences 18(3): 55–82.
Mulholland, A. (2017) Study finds MS vein therapy ineffective, questions remain. CTV News, 8 March, http://www.ctvnews.ca/health/study-finds-ms-vein-therapy-ineffective-questions-remain-1.3315927, accessed 18 March 2017.
Murdoch, C.E. and Scott, C.T. (2010) Stem cell tourism and the power of hope. The American Journal of Bioethics 10(5): 16–23.
NICE (2012) Percutaneous venoplasty for chronic cerebrospinal venous insufficiency for multiple sclerosis: Interventional procedures guidance [IPG420]. March, https://www.nice.org.uk/guidance/ipg420, accessed 12 November 2016.
Nicolson, M. and McLaughlin, C. (1988) Social constructionism and medical sociology: A study of the vascular theory of multiple sclerosis. Sociology of Health and Illness 10(3): 234–261.
Nicolson, M. and Lowis, G.W. (2002) The early history of the Multiple Sclerosis Society of Great Britain and Northern Ireland: A socio-historical study of lay/practitioner interaction in the context of a medical charity. Medical History 46(2): 141–174.
Novas, C. (2006) The political economy of hope: Patients’ organizations, science and biovalue. BioSocieties 1(03): 289–305.
Ong, L.M.L., de Haes, J.C., Hoos, A.M. and Lammes, F.B. (1995) Doctor-patient communication: A review of the literature. Social Science and Medicine 40(7): 903–918.
Petersen, A., Seear, K. and Munsie, M. (2014) Therapeutic journeys: The hopeful travails of stem cell tourists. Sociology of Health and Illness 36(5): 670–685.
Petersen, A., Tanner, C. and Munsie, M. (2015) Between hope and evidence: How community advisors demarcate the boundary between legitimate and illegitimate stem cell treatments.” Health 19(2): 188–206.
Petersen, A. and Wilkinson, I (2015) Editorial introduction: The sociology of hope in contexts of health, medicine, and healthcare. Health 19(2): 11318.
Ploughman, M., Harris, C., Hogan, S.H., Murray, C., Murdoch, M., Austin, M.W. and Stefanelli, M. (2014) Navigating the ‘liberation procedure’: A qualitative study of motivating and hesitating factors among people with multiple sclerosis. Patient Preference and Adherence 8: 1205–1213.
Prasad, A. (2015) Ambivalent journeys of hope: Embryonic stem cell therapy in a clinic in India. Health 19(2): 137–153.
Rabeharisoa, V., Moreira, T. and Akrich, M. (2014) Evidence-based activism: Patients’, users’ and activists’ groups in knowledge society. BioSocieties 9(2): 111–128.
Ratislavová, K. and Ratislav, J. (2014) Asynchronous email interview as a qualitative research method in the humanities. Human Affairs 24(4): 452–460.
Reekers, J.A. (2012) CCSVI and MS: A neverending story. European Journal of Vascular and Endovascular Surgery 43: 127–128.
Rhodes, M.A. (2011) CCSVI as the Cause of Multiple Sclerosis: The Science Behind the Controversial Theory. Jefferson: McFarland & Co Inc.
Rhodes, T., Bernays, S. and Janković Terzić, K. (2009) Medical promise and the recalibration of expectation: Hope and HIV treatment engagement in a transitional setting. Social Science and Medicine 68(6): 1050–1059.
Robinson, I. (1990) Personal narratives, social careers and medical courses: Analysing life trajectories in autobiographies of people with multiple sclerosis. Social Science and Medicine 30(11): 1173–1186.
Rothwell, P.M., McDowell, Z., Wong, C.K. and Dorman, P.J. (1997) Doctors and patients don’t agree: Cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. British Medical Journal 314: 1580–1580.
Shapiro, A.K. and Shapiro, E. (1997) The Placebo: Is it Much Ado about Nothing? In A. Harrington (ed.) The Placebo Effect. Cambridge MA: Harvard University Press, pp. 12–36.
Snyder, J., Adams, K., Crooks, V.A., Whitehurst, D. and Vallee, J. (2014) ‘I knew what was going to happen if I did nothing and so I was going to do something’: Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek unproven interventions abroad. BMC Health Services Research 14: 445.
Song, P. (2010) Biotech pilgrims and the transnational quest for stem cell cures. Medical Anthropology 29(4): 384–402.
Sosnowy, C. (2014) Practicing patienthood online: Social media, chronic illness, and lay expertise. Societies 4(2): 316–329.
Stewart, D.C., and Sullivan, T.J. (1982) Illness behavior and the sick role in chronic disease: The case of multiple sclerosis. Social Science and Medicine 16(15): 1397–1404.
Stolz, E. (2015) Chronic cerebrospinal venous insufficiency: The end of ‘the big idea’? Brain and Behavior 5(1): 1–2.
Sudau, F., Friede, T., Grabowski, J., Koschack, J., Makedonski, P. and Himmel, W. (2014) Sources of information and behavioral patterns in online health forums: Observational study. Journal of Medical Internet Research 16(1): e10.
Traboulsee, A.L., Knox, K.B. Machan, L., Zhao, Y., Yee, I., Rauscher, A. and Klass, D. (2014) Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: A blinded, case-control study. Lancet 383(9912): 138–145.
Trojano, M., Paolicelli, D., Bellacosa, A. and Cataldo, S. (2003) The transition from relapsing-remitting MS to irreversible disability: Clinical evaluation. Neurological Sciences 24(5): s268–s270.
Tsivgoulis, G., Faissner, S. Voumvourakis, K., Katsanos, A.H., Triantafyllou, N., Grigoriadis, N., Gold, R. and Krogias, C. (2015) ‘Liberation treatment’ for chronic cerebrospinal venous insufficiency in multiple sclerosis: The truth will set you free. Brain and Behavior 5(1): 3–12.
Turner, L. (2007) ‘First world health care at third world prices’: Globalization, bioethics and medical tourism. BioSocieties 2(3): 303–325.
Ubelacker, S. (2012) US FDA warns against controversial liberation therapy for MS. National Post, 10 May, http://news.nationalpost.com/news/u-s-fda-warns-against-controversial-liberation-therapy-for-ms, accessed 12 November 2016.
Vera, C., Herr, A., Mandato, K., Englander, M., Ginsburg, L. and Siskin, G.P. (2012) Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency. Techniques in Vascular and Interventional Radiology 15(2): 153–157.
Whelan, E. (2007) ‘No one agrees except for those of us who have it’: endometriosis patients as an epistemological community. Sociology of Health and Illness 29(7): 957–982.
Whittaker, A., Manderson, L. and Cartwright, E. (2010) Patients without borders: Understanding medical travel. Medical Anthropology 29(4): 336–343.
Wilkerson, J.M., Iantaffi, A., Grey, J.A., Bockting, W.O. and Rosser, B.R.S. (2014) Recommendations for internet-based qualitative health research with hard-to-reach populations.” Qualitative Health Research 24(4): 561–574.
Wong, C., Fox, R. and Rae-Grant, A. (2012) The history of the vascular theories of multiple sclerosis (S59.006). Neurology 78 (Meeting Abstracts 1): S59.006.
Zamboni, P. (2006) The big idea: Iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. Journal of the Royal Society of Medicine 99(11): 589–593.
Zamboni, P., Galeotti, R. Menegatti, E., Malagoni, A.M., Gianesini, S. Bartolomei, I., Mascoli, F. and Salvi, F. (2009a) A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery 50(6): 1348–1358.
Zamboni, P., Galeotti, R., Menegatti, E., Malagoni, A.M., Tacconi, G., Dall’Ara, S., Bartolomei, I. and Salvi, F. (2009b) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 80(4): 392–399.
Acknowledgements
The authors would like to thank all our interviewees; without your generosity this research would not have been possible. We would also like to thank Kerri Cassidy for giving us permission to cite her YouTube video and for providing feedback on the final draft of the paper. Fadhila Mazanderani would like to thank the NIHR who provided funding for her work as part of the iPEx programme. She would also like to thank members of the iPEx programme for discussions that contributed to the ideas put forward in the paper, especially John Powell. The iPEx programme presents independent research funded by the NIHR under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10147). The views expressed in this article are those of the authors, representing iPEx, and not necessarily those of the NHS, the NIHR or the Department of Health. Jenny Kelly would like to thank the Canadian Institutes of Health Research who provided funding through their Master’s Award: Frederick Banting and Charles Best Canada Graduate Scholarships (#218607). Andy Byford provided invaluable feedback on an early draft of the paper for which the authors are very grateful.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mazanderani, F., Kelly, J. & Ducey, A. From embodied risk to embodying hope: Therapeutic experimentation and experiential information sharing in a contested intervention for Multiple Sclerosis. BioSocieties 13, 232–254 (2018). https://doi.org/10.1057/s41292-017-0066-z
Published:
Issue Date:
DOI: https://doi.org/10.1057/s41292-017-0066-z